An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders
Eur J Nucl Med Mol Imaging
.
2020 Jan;47(1):18-27.
doi: 10.1007/s00259-019-04490-6.
Epub 2019 Sep 4.
Authors
Abass Alavi
1
,
Søren Hess
2
3
,
Thomas J Werner
4
,
Poul Flemming Høilund-Carlsen
3
5
Affiliations
1
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA. abass.alavi@uphs.upenn.edu.
2
Department of Radiology and Nuclear Medicine, Hospital of Southwest Jutland, Esbjerg, Denmark.
3
Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
4
Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
5
Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
PMID:
31482427
DOI:
10.1007/s00259-019-04490-6
No abstract available
Publication types
Editorial
MeSH terms
Fluorodeoxyglucose F18*
Humans
Positron-Emission Tomography*
Radiopharmaceuticals
Substances
Radiopharmaceuticals
Fluorodeoxyglucose F18